In January 1897, attorney P.H. Nelson left his position as solicitor of the Fifth Judicial Circuit to set up a private law practice in Columbia, S.C. The State newspaper contained a short but prescient news item on Jan. 26 about the endeavor, which noted that "the new firm should meet with great success."
And they were right. Today, Nelson Mullins Riley & Scarborough LLP offers legal services in 15 states and the District of Columbia from 31 offices with 930+ attorneys, policy advisors, and professionals. It is the 71st largest law firm in the nation based on 2020 gross revenues, according to The American Lawyer’s Am Law 100, a legal news organization that tracks law firm growth.
Throughout 2022, Nelson Mullins will be sharing seminal events from its history that highlight its growth from a one-man firm in 1897 to where we are today. Click here to learn more.
May 6, 2022
New data published by the Centers for Disease Control and Prevention (“CDC”) indicates that the divide between rural and urban areas in COVID-19 primary vaccination coverage has more than doubled in under a year.
Vaccine Hesitancy and the Growing Divideour team of patent attorneys, litigators, and technical specialists work with biotechnology start-ups and leading pharmaceutical companies to enhance strategic thinking and provide creative solutions.
Nelson Mullins’ Life Sciences team is known for developing and implementing effective IP strategies and building strong patent portfolios. These practices protect and facilitate commercialization of products for companies ranging from biotechnology start-ups to leading pharmaceutical companies.
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
Our attorneys, patent agents, and technical specialists include staff immunologists and molecular biologists who are graduates or postdoctoral fellows from top universities, including Brown, Cornell, Harvard, Stanford, MIT, Tufts, and McGill.
We have knowledge of life science and antibody discovery / development technologies including
Our attorneys, patent agents, and technical specialists include chemists who have doctoral and undergraduate degrees, as well as postdoctoral and industry experience in a variety of chemical arts, including synthetic organic, inorganic, and bioorganic chemistry, as well as chemical engineering and chemical processing.
We have worked with clients in many areas of chemistry patent prosecution and due diligence including
Our team of attorneys and senior patent agents includes immunologists with Ph.D. degrees from Harvard University and graduate and post-doctoral experience from top research universities, institutions, and companies. Because of our experience in the immunology area and our reasonable billing rates, we are able to complete projects efficiently and cost effectively. We work with clients to develop budgets and project goals.
We have worked with clients in many technical areas of immunology patent prosecution and due diligence including
We assess the costs and risks of patent litigation, and alternative resolutions, when our clients are involved in developing new technologies or engaged in due diligence. Our litigation risk assessments enable clients to make informed business decisions when contemplating whether to commence litigation, how to respond to cease and desist letters, and how to defend against lawsuits that have been filed against them.
Nelson Mullins’ Life Sciences team is known for developing and implementing effective IP strategies and building strong patent portfolios. These practices protect and facilitate commercialization of products for companies ranging from biotechnology start-ups to leading pharmaceutical companies.
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
Our attorneys, patent agents, and technical specialists include staff immunologists and molecular biologists who are graduates or postdoctoral fellows from top universities, including Brown, Cornell, Harvard, Stanford, MIT, Tufts, and McGill.
We have knowledge of life science and antibody discovery / development technologies including
Our attorneys, patent agents, and technical specialists include chemists who have doctoral and undergraduate degrees, as well as postdoctoral and industry experience in a variety of chemical arts, including synthetic organic, inorganic, and bioorganic chemistry, as well as chemical engineering and chemical processing.
We have worked with clients in many areas of chemistry patent prosecution and due diligence including
Our team of attorneys and senior patent agents includes immunologists with Ph.D. degrees from Harvard University and graduate and post-doctoral experience from top research universities, institutions, and companies. Because of our experience in the immunology area and our reasonable billing rates, we are able to complete projects efficiently and cost effectively. We work with clients to develop budgets and project goals.
We have worked with clients in many technical areas of immunology patent prosecution and due diligence including
We assess the costs and risks of patent litigation, and alternative resolutions, when our clients are involved in developing new technologies or engaged in due diligence. Our litigation risk assessments enable clients to make informed business decisions when contemplating whether to commence litigation, how to respond to cease and desist letters, and how to defend against lawsuits that have been filed against them.
We use cookies to improve functionality and performance of our website and to provide you with the best possible browsing experience. These cookies include those which are strictly necessary for website operation, as well as those which are used for functionality and performance purposes.
For more information on how our Sites use cookies, click here to view our Cookie Policy.